Summary
Brian Tsui is an applied scientist with 11 years of experience applying machine learning, distributed computing, and complexity-theoretic ideas to translate high-dimensional biomedical and transactional data into production-ready systems. Currently at Amazon HealthAI, he leads GenAI-driven drug discovery efforts and previously pioneered Mixture-of-Experts research and fraud-evaluation pipelines for high-risk transactions. His background blends a PhD in bioinformatics and impactful industry work—optimizing DRAGEN methylation and HLA modules, helping enable the first sequencing-based FDA EUA COVID-19 test, and advancing liquid biopsy variant calling. He has a track record of squeezing performance from hardware and software (3x runtime improvements and 10x disk reductions) and adapting algorithms to run efficiently on compressed data. Based in Palo Alto, he brings both deep research pedigree (1,000+ citations from his PhD work) and hands-on production experience across AWS, Guardant Health, and Illumina. Colleagues rely on him to bridge rigorous algorithmic thinking with pragmatic engineering to move complex computational biology projects into scale.
11 years of coding experience
8 years of employment as a software developer
University of California, San Diego
English, Chinese